| Patent Number |
Title Of Patent |
Date Issued |
| 6960351 |
Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products |
November 1, 2005 |
| An immunoisolatory vehicle for the implantation into an individual of cells which produce a needed product or provide a needed metabolic function. The vehicle is comprised of a core region containing isolated cells and materials sufficient to maintain the cells, and a permselective, |
| 6322804 |
Implantable biocompatible immunoisolatory vehicle for the delivery of selected therapeutic produ |
November 27, 2001 |
| An immunoisolatory vehicle for the implantation into an individual of cells which produce a needed product or provide a needed metabolic function. The vehicle is comprised of a core region containing isolated cells and materials sufficient to maintain the cells, and a permselective, |
| 6083523 |
Implantable biocompatable immunoisolatory vehicle for delivery of selected therapeutic products |
July 4, 2000 |
| An immunoisolatory vehicle for the implantation into an individual of cells which produce a needed product or provide a needed metabolic function. The vehicle is comprised of a core region containing isolated cells and materials sufficient to maintain the cells, and a permselective, |
| 5874099 |
Methods for making immunoisolatary implantable vehicles with a biocompatible jacket and a biocom |
February 23, 1999 |
| A method of forming an implantable and retrievable immunoisolatory vehicles is disclosed, the method comprising the steps of first forming a core comprising a volume of at least 1 .mu.l and at least 10.sup.4 cells capable of providing a biologically active product or metabolic or imm |
| 5871767 |
Methods for treatment or prevention of neurodegenerative conditions using immunoisolatory implan |
February 16, 1999 |
| A method for treatment of a neurodegenerative condition in a patient comprising implanting in the patient at least one immunoisolatory vehicle comprising a corc comprising a volume of at least 1 .mu.l and at least 10.sup.4 living cells which secrete at least one biologically active p |
| 5869077 |
Methods for treating diabetes by delivering insulin from biocompatible cell-containing devices |
February 9, 1999 |
| A method for treating diabetes in a patient comprising subcutaneously implanting in the patient at least one immunoisolatory vehicle comprising a core comprising a volume of at least 1 .mu.l and at least about 10.sup.4 living cells which secrete insulin, said cells being dispersed in a |
| 5834001 |
Methods for making immunoisolatory implantable vehicles with a biocompatiable jacket and a bioco |
November 10, 1998 |
| A method of forming an implantable and retrievable immunoisolatory vehicle is disclosed, the method comprising the steps of first forming a jacket of biocompatible thermoplastic or hydrogel, and then loading the jacket with a core comprising a volume of at least 1 .mu.l and at least 10.s |
| 5800829 |
Methods for coextruding immunoisolatory implantable vehicles with a biocompatible jacket and a b |
September 1, 1998 |
| A method of making an immunoisolatory vehicle comprised of a core comprising living cells dispersed in a biocompatible matrix is disclosed, the cells being capable of secreting a biologically active product or of providing a metabolic or immunologic function to an individual, and an |
| 5800828 |
Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products |
September 1, 1998 |
| Immunoisolatory vehicles having a core and a surrounding jacket are disclosed, the core having a volume in excess of 1 .mu.l and at least about 10.sup.4 living cells capable of secreting a biologically active product or of providing a biological function to a patient, the cells dispe |
| 5798113 |
Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products |
August 25, 1998 |
| A method of providing a biologically active molecule or metabolic or immunologic function to a patient, comprising implanting into the body of the patient at least one immunoisolatory vehicle comprising a core comprising a volume in excess of 1 .mu.l and at least about 10.sup.4 livin |
